Hematological, biochemical, serological, and molecular monitoring of blood donor dogs vaccinated with CaniLeish® for the prevention of Leishmaniosis
- 52 Downloads
The use of systemic preventive measures in dogs living in areas with Leishmania infection is advisable, particularly in blood donors. The aim of this study was to monitor healthy blood-donor dogs immunized with the vaccine CaniLeish® by means of hematological, biochemical (serum total protein, albumin, protein electrophoresis, and C-reactive protein), serological (Speed Leish K™ and IFAT), and molecular assays (qualitative PCR, qlPCR). Twenty-four dogs were monitored at (T0), second (T1), third (T2) immunizations, and 2 months (T3) after the initial immunization and at the first (T4), second (T5), and third (T6) annual booster. The results were as follows: slight hyperproteinemia (29.5%, p > 0.05) observed throughout the monitoring period (T0-T6); increase in C-reactive protein (46.4%, p < 0.05) (at T3-T6); significant alterations in β-1 and β-2 globulin fractions (as absolute and percentage values, p < 0.05), Speed Leish K™ assay negative at T0 and T4-T6, positive IFAT titres of 1/40 (9.5%) at T0, and T3-T6, 1/80 (8.6%) at T1-T4, 1/160 (6.7%) at T1-T2 and T4, and 1/320 (1.9%) at T2 and T4; and qlPCR positive in 7.7% of samples at T3-T6. The vaccination with Canileish® induced changes in a few clinico-pathological and serological markers, which are likely associated with the activation of the immune response. These changes should be carefully considered when evaluating vaccinated dogs included in blood transfusion programs. The use of the CaniLeish® vaccine could be recommended as an additional preventive measure and could represent an important practice in the field of canine transfusion medicine.
KeywordsCaniLeish® Blood donor-dogs PCR Serology Leishmaniosis Vector-borne diseases
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
- Bongiorno G, Paparcone R, Foglia Manzillo V, Oliva G, Cuisinier AM, Gradoni L (2013) Vaccination with LiESP/QA-21 (CaniLeish®) reduces the intensity of infection in Phlebotomus perniciosus fed on Leishmania infantum infected dogs—a preliminary xenodiagnosis study. Vet Parasitol 197:691–695CrossRefPubMedGoogle Scholar
- Ciaramella P, Corona M (2003) Canine Leishmaniasis: clinical and diagnostic aspects. Coompendiun on Continuing Education for the Practising. Vet N Am Ed 25(5):358–369Google Scholar
- EFSA AHAW Panel (EFSA Panel on Animal Health and Welfare) (2015) Scientific opinion on canine leishmaniosis. Eur Food Saf Authority J 13(4):1–77Google Scholar
- El Tai NO, Osman OF, El Fari M, Presber W, Schönian G (2000) Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single-strand conformation polymorphisms and sequencing. Trans R Soc Trop Med Hyg 94(5):575–579CrossRefPubMedGoogle Scholar
- EMA (European Medicines Agency) (2011) Scientific discussion. EMA/CVMP/296057/2010. Veterinary medicines and product data managementGoogle Scholar
- Ferroglio E, Zanet S, Mignone W, Poggi M, Trisciuoglio A, Bianciardi P (2013) Evaluation of a rapid device for serological diagnosis of Leishmania infantum infection in dogs as an alternative to immunofluorescence assay and western blotting. Clin Vaccine Immunol 20(5):657–659CrossRefPubMedPubMedCentralGoogle Scholar
- Martin V, Vouldoukis I, Moreno J, McGahie D, Gueguen S, Cuisinier AM (2014) The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish®) remains effective against an experimental challenge one year later. Vet Res 45(1):69CrossRefPubMedPubMedCentralGoogle Scholar
- Ministero della Salute (Italian Ministry of Health) (2016) Linea guida per l’esercizio delle attività sanitarie riguardanti la medicina trasfusionale in campo veterinario (Guidelines concerning the practice of health procedures about veterinary transfusion medicine) Official Journal 25:5–18Google Scholar
- Oliva G, Nieto J, Foglia Manzillo V, Cappiello S, Fiorentino E, Di Muccio T, Scalone A, Moreno J, Chicharro C, Carrillo E, Butaud T, Guegand L, Martin V, Cuisinier AM, McGahie D, Gueguen S, Canavate C, Gradoni L (2014) A randomised, double-blind, controlled efficacy trial of the LiESP/QA-21 vaccine in Naïve dogs exposed to two Leishmania infantum transmission seasons. PLoS Negl Trop Dis 8(10):e3213CrossRefPubMedPubMedCentralGoogle Scholar
- Rotondi S (2013) Diagnosi della Leishmaniosi canina: Speed Leish K e l’interesse delle kinesine. Virbacnews n.1-Speciale leishmaniosiGoogle Scholar
- Sagols E, Martin V, Claret E, McGahie D, Ciusinier AM, Gueguen S (2012) Evaluation of the humoral immune response after vaccination with LiESP/QA- 21 (CaniLeish): interest of Leishmania specific anti-kinesin antibodies detection. In Proceedings of the WSAVA/FECAVA/BSAVA CongressGoogle Scholar
- Sagols E, Ferraz F, Claret E, McGahie D (2013) Follow up of the humoral immune response after the first annual CaniLeish® booster vaccination. In Proceedings of the Southern European Veterinary Conference (SEVC’13)Google Scholar
- Solano-Gallego L, Villanueva-Saz S, Carbonell M, Trotta M, Furlanello T, Natale A (2014) Serological diagnosis of canine leishamniosis: comparison of three commercial ELISA tests (Leiscan®, ID screen® and Leishmania 96®), a rapid test (Speed Leish K™) and an in-house IFAT. Parasites Vectors 7(111):10Google Scholar
- Starita C, Gavazza A, Lubas G (2016) Hematological, biochemical, and serological findings in healthy canine blood donors after the administration of CaniLeish® Vaccine. Vet Med Int 4601893:6Google Scholar